Evaluation of the 24/7 EEG SubQ System for Ultra Long-Term Recording of Patients With Epilepsy Involving the Temporal Lobe Region.
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Michael Gelfand
University of Pennsylvania
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
12 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Hopital Erasme - Universite Libre de Bruxelles
Brussels, Belgium
- Krankenhaus Mara, Gesellschaft Für Epilepsieforschung E.V.
Bielefeld, Germany
- Universität Klinikum Freibrug
Freiburg im Breisgau, Germany
- University of California
Los Angeles, California, United States
- University of South Florida (usf) Neurology Department
Tampa, Florida, United States
- Massachusetts General Hospital
Boston, Massachusetts, United States
- Mayo Clinic
Rochester, Minnesota, United States
- Hackensack Meridian Health
Neptune City, New Jersey, United States
- Northwell Health Department of Neurosurgery
Great Neck, New York, United States
- Cleveland Clinic, Neurological Institute
Cleveland, Ohio, United States
- University of Pennsylvenia
Philadelphia, Pennsylvania, United States
- Ut Health Houston
Houston, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 21 Apr 2021
- Primary completion
- 22 Jul 2025
- Completion
- 29 Aug 2025
- Last update posted
- 5 Sept 2025
- Registered enrollment
- 64
- Registry id
- NCT04526418
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.